Targeting Anti-apoptotic Bcl-2 Proteins with Scyllatoxin-based BH3 Domain Mimetics
Year: 2020
Type: article
Abstract: Molecules that inhibit discrete protein-protein (PPIs) interactions hold immense promise to be developed as therapeutics or chemical genetics agents.The B cell lymphoma 2 (BCL-2) proteins are a family of evolutionarily-related proteins that act as positive or negative regulators of the intrinsic apoptosis pathway.Proteins in the BCL-2 family are primarily categorized into three sub types: anti-apoptotic (pro-survival) proteins, pro-apoptotic (pro-death) proteins and BH3-only proteins.Overexpression of anti-apoptotic BCL-2 proteins in cells is associated with apoptotic resistance, which can result in cancerous phenotypes or pathogenic cell survival.As a consequence, antiapoptotic BCL-2 proteins have attracted considerable interest as therapeutic targets.Antiapoptotic BCL-2 proteins bind to helical BH3 domains of pro-apoptotic proteins through a shallow, hydrophobic cleft.These pro-apoptotic proteins remain inactive when bound to anti-apoptotic members.BH3-only proteins are expressed under cell stress conditions to prevent interaction between ant-apoptotic BCL-2 and pro apoptotic proteins, which eventually leads to apoptosis initiation.Unfortunately, non-specific interactions between BCL-2 family members has made it difficult to elucidate specific mechanisms of BCL-2 signaling.Molecules that clearly define such interactions would be beneficial in the development of therapeutics that target specific proteins in the BCL-2 family.Scyllatoxin (ScTx) is a 31-amino acid protein isolated from scorpion venom that folds into α/β LIST OF ABBREVIATIONS Abu………………………………………………………………………aminobutyric acid ACDR………………………………….aminocylcopropanedeaminase regulatory protein ACP……………………………………………………………………acyl carrier protein ACM……………………………………………………………………...acetamidomethyl ACN…………………………………………………………………………….acetonitrile AML………………………………………………………………acute myeloid leukemia AIF…………………………………………………………………apoptosis induce factor Arg…………………………………………………………………………………arginine Asp…………………………………………………………………………….aspartic acid Apaf1………………………………………………..apoptosis protease activating factor 1 ATP………………………………………………………………...adenosine triphosphate ATRIP…………………………………….ataxia telangiectasia related interacting protein Bak………………………………………………………………...BCL-2 antagonist killer Bax……………………………………………………………...Bcl-2 associated x protein BCL-2…………………………………………………………………..B-cell lymphoma 2 BH………………………………………………………………………..BCL-2 homology BID……………………………………………………......BH3 interacting domain protein BmBKTX………………………………………Buthus martensi Karsch K + channel toxin CAD………..carbamyl-phosphate synthetase, aspartate transcarbamylase, dihydroorotase CCR5……………………………………………………...C-C chemokine receptor type 5 CD4……………………………………………………………..cluster of differentiation 4 CD……………………………………………………………………….circulardichroism CF……………………………………………………………………...carboxy fluorescein CLL…………………………………………………………chronic lymphocyte leukemia Cys…………………………………………………………………………………cysteine DIABLO…………………………...
Author: Berugoda Arachchige, Danushka M.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7071488824
